pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 10·1 min read
save

AI sepsis tools face timing challenges, says STAT AI Prognosis newsletter

Jun 10, 2026·read at STAT ↗Neutral

The latest STAT AI Prognosis newsletter notes that current sepsis detection algorithms sometimes require data from future time points, which is unrealistic.

The piece highlights how such quirks in medical data can mislead AI models and calls for more robust design that works with real‑time information.

The newsletter also mentions other AI topics, including AI‑generated clinical notes and recent biotech AI developments, while inviting readers to share feedback and subscribe.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Your sepsis algorithm shouldn’t require a time machine”

read at STAT ↗
469 words · retrieved Jun 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATH

related stories

  • May 12Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugBioPharma Dive
  • May 12Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Riskonclive
  • May 11CSL sinks to nine-year low on revenue warning, $5B write-downEndpoints
  • May 11Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesBioPharma Dive
  • May 11Opinion: AI doctors should be licensed. Here’s a framework to do thatSTAT